CleanSpace Writes Off NSW Health Loan, Booking $2.8m Gain

CleanSpace Holdings Ltd. ( (AU:CSX) ) has provided an update.

CleanSpace Holdings has reclassified a $2.8 million funding loan from the NSW Health Administration Corporation, awarded under the Medical Device Funding program in 2019, from a long-term liability to nil on its balance sheet as at 31 December 2025. The move follows the board’s assessment that the respirator project supported by the loan has not met commercial success milestones, with related sales contributing less than 0.5% of revenue in recent years and cumulative EBITDA remaining negative.

The accounting change, made under AASB 9 guidance and backed by external expert advice, will result in a $2.8 million uplift in ‘other gains’ in CleanSpace’s H1FY26 profit and loss statement. Management will reassess the likelihood of future commercial success and potential cash flows at each annual reporting date, with any renewed liability to be remeasured through the profit and loss, underscoring a more conservative stance on the project’s prospects while modestly improving near-term earnings.

The most recent analyst rating on (AU:CSX) stock is a Hold with a A$0.56 price target. To see the full list of analyst forecasts on CleanSpace Holdings Ltd. stock, see the AU:CSX Stock Forecast page.

More about CleanSpace Holdings Ltd.

CleanSpace Holdings Limited is a Sydney-based designer and manufacturer of premium respiratory protection equipment for industrial and healthcare markets. Founded by biomedical engineers with experience in respiratory medical devices, the company focuses on differentiated, high-protection respirators that aim to improve safety standards and health outcomes for frontline workers globally.

Average Trading Volume: 26,347

Technical Sentiment Signal: Sell

Current Market Cap: A$47.42M

See more data about CSX stock on TipRanks’ Stock Analysis page.